CPHD » Topics » TABLE OF CONTENTS

These excerpts taken from the CPHD 10-K filed Feb 26, 2009.

TABLE OF CONTENTS

 

          Page
Part I.      
Item 1.    Business    3
Item 1A.    Risk Factors    12
Item 1B.    Unresolved Staff Comments    20
Item 2.    Properties    20
Item 3.    Legal Proceedings    20
Item 4.    Submission of Matters to a Vote of Security Holders    20
Part II.      
Item 5.    Market for the Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities    21
Item 6.    Selected Consolidated Financial Data    23
Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    24
Item 7A.    Quantitative and Qualitative Disclosures about Market Risks    37
Item 8.    Consolidated Financial Statements and Supplementary Data    39
Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    70
Item 9A.    Controls and Procedures    70
Item 9B.    Other Information    70
Part III.      
Item 10.    Directors, Executive Officers and Corporate Governance    71
Item 11.    Executive Compensation    71
Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters    71
Item 13.    Certain Relationships and Related Transactions, and Director Independence    71
Item 14.    Principal Accountant Fees and Services    71
Part IV.      
Item 15.    Exhibits, Financial Statement Schedules    72
Signatures    74

 

 

Cepheid®, the Cepheid logo, GeneXpert®, Xpert®, SmartCycler®, SmartCycler II, SmartCap®, I-CORE®, SmartMix®, OmniMix®, affigene®, Sangtec®, and Actigenics are trademarks of Cepheid. All other trademarks, service marks or trade names referred to in this report are the property of their respective owners.

 

2


Table of Contents

TABLE OF CONTENTS

 

          Page
Part I.      
Item 1.    Business    3
Item 1A.    Risk Factors    12
Item 1B.    Unresolved Staff Comments    20
Item 2.    Properties    20
Item 3.    Legal Proceedings    20
Item 4.    Submission of Matters to a Vote of Security Holders    20
Part II.      
Item 5.    Market for the Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities    21
Item 6.    Selected Consolidated Financial Data    23
Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    24
Item 7A.    Quantitative and Qualitative Disclosures about Market Risks    37
Item 8.    Consolidated Financial Statements and Supplementary Data    39
Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    70
Item 9A.    Controls and Procedures    70
Item 9B.    Other Information    70
Part III.      
Item 10.    Directors, Executive Officers and Corporate Governance    71
Item 11.    Executive Compensation    71
Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters    71
Item 13.    Certain Relationships and Related Transactions, and Director Independence    71
Item 14.    Principal Accountant Fees and Services    71
Part IV.      
Item 15.    Exhibits, Financial Statement Schedules    72
Signatures    74

 

 

Cepheid®, the Cepheid logo, GeneXpert®, Xpert®, SmartCycler®, SmartCycler II, SmartCap®, I-CORE®, SmartMix®, OmniMix®, affigene®, Sangtec®, and Actigenics are trademarks of Cepheid. All other trademarks, service marks or trade names referred to in this report are the property of their respective owners.

 

2


Table of Contents
These excerpts taken from the CPHD 10-K filed Feb 29, 2008.
TABLE OF CONTENTS
 
 
             
        Page
 
  Business     1  
  Risk Factors     10  
  Unresolved Staff Comments     20  
  Properties     20  
  Legal Proceedings     20  
  Submission of Matters to a Vote of Security Holders     20  
 
PART II.
  Market for the Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of the Equity Securities     21  
  Selected Consolidated Financial Data     24  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     25  
  Quantitative and Qualitative Disclosures about Market Risks     39  
  Consolidated Financial Statements and Supplementary Data     41  
  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure     71  
  Controls and Procedures     72  
  Other Information     72  
 
PART III.
  Directors, Executive Officers and Corporate Governance     72  
  Executive Compensation     72  
  Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters     72  
  Certain Relationships and Related Transactions, and Director Independence     73  
  Principal Accountant Fees and Services     73  
 
PART IV.
  Exhibits and Financial Statement Schedules     73  
        75  
 EXHIBIT 10.39
 EXHIBIT 10.40
 EXHIBIT 21.1
 EXHIBIT 23.1
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2
 
Cepheid®, the Cepheid logo, SmartCycler®, GeneXpert® and I-CORE® and affigene® are registered trademarks of Cepheid. SmartCycler II, Xpert, Actigenics and Sangtec are trademarks of Cepheid. All other trademarks, service marks or trade names referred to in this report are the property of their respective owners.


Table of Contents

TABLE OF
CONTENTS



 









 


















































































































































































































































             

 

 

 

 

Page
 





 

Business

 
 

1
 



 

Risk Factors

 
 

10
 



 

Unresolved Staff Comments

 
 

20
 



 

Properties

 
 

20
 



 

Legal Proceedings

 
 

20
 



 

Submission of Matters to a Vote of Security
Holders


 
 

20
 

 

PART II.



 

Market for the Registrant’s Common Equity,
Related Shareholder Matters and Issuer Purchases of the Equity
Securities


 
 

21
 



 

Selected Consolidated Financial Data

 
 

24
 



 

Management’s Discussion and Analysis of
Financial Condition and Results of Operations


 
 

25
 



 

Quantitative and Qualitative Disclosures about
Market Risks


 
 

39
 



 

Consolidated Financial Statements and
Supplementary Data


 
 

41
 



 

Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure


 
 

71
 



 

Controls and Procedures

 
 

72
 



 

Other Information

 
 

72
 

 

PART III.



 

Directors, Executive Officers and Corporate
Governance


 
 

72
 



 

Executive Compensation

 
 

72
 



 

Security Ownership of Certain Beneficial Owners
and Management and Related Shareholder Matters


 
 

72
 



 

Certain Relationships and Related Transactions,
and Director Independence


 
 

73
 



 

Principal Accountant Fees and Services

 
 

73
 

 

PART IV.



 

Exhibits and Financial Statement Schedules

 
 

73
 



 

 

 
 

75
 
 EXHIBIT 10.39
 EXHIBIT 10.40
 EXHIBIT 21.1
 EXHIBIT 23.1
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2










 



Cepheid®,
the Cepheid logo,
SmartCycler®,
GeneXpert®
and
I-CORE®
and
affigene®
are registered trademarks of Cepheid. SmartCycler II, Xpert,
Actigenics and Sangtec are trademarks of Cepheid. All other
trademarks, service marks or trade names referred to in this
report are the property of their respective owners.








Table of Contents







This excerpt taken from the CPHD 10-K filed Mar 15, 2007.
TABLE OF CONTENTS
 
                 
        Page
 
  Business   1
  Risk Factors   10
  Unresolved Staff Comments   20
  Properties   20
  Legal Proceedings   20
  Submission of Matters to a Vote of Security Holders   20
 
  Market for the Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of the Equity Securities   20
  Selected Consolidated Financial Data   21
  Management’s Discussion and Analysis of Financial Condition and Results of Operations   22
  Quantitative and Qualitative Disclosures about Market Risks   35
  Consolidated Financial Statements and Supplementary Data   36
  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   63
  Controls and Procedures   63
  Other Information   63
 
  Directors, Executive Officers and Corporate Governance   64
  Executive Compensation   64
  Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters   64
  Certain Relationships and Related Transactions, and Director Independence   64
  Principal Accountant Fees and Services   64
 
  Exhibits and Financial Statement Schedule   65
  67
 EXHIBIT 21.1
 EXHIBIT 23.1
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2
 
 
Cepheid®, the Cepheid logo, SmartCycler®, GeneXpert® and I-CORE® are registered trademarks of Cepheid. SmartCycler II, Actigenics and Sangtec are trademarks of Cepheid. All other trademarks, service marks or trade names referred to in this report are the property of their respective owners.


Table of Contents

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki